These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 35638041)

  • 41. Effects of neuromuscular blockers on transpulmonary pressures in moderate to severe acute respiratory distress syndrome.
    Guervilly C; Bisbal M; Forel JM; Mechati M; Lehingue S; Bourenne J; Perrin G; Rambaud R; Adda M; Hraiech S; Marchi E; Roch A; Gainnier M; Papazian L
    Intensive Care Med; 2017 Mar; 43(3):408-418. PubMed ID: 28013329
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Paralytics in critical care: not always the bad guy.
    Forel JM; Roch A; Papazian L
    Curr Opin Crit Care; 2009 Feb; 15(1):59-66. PubMed ID: 19186410
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Neuromuscular blockade in patients with ARDS: a rapid practice guideline.
    Alhazzani W; Belley-Cote E; Møller MH; Angus DC; Papazian L; Arabi YM; Citerio G; Connolly B; Denehy L; Fox-Robichaud A; Hough CL; Laake JH; Machado FR; Ostermann M; Piraino T; Sharif S; Szczeklik W; Young PJ; Gouskos A; Kiedrowski K; Burns KEA
    Intensive Care Med; 2020 Nov; 46(11):1977-1986. PubMed ID: 33104824
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Early Neuromuscular Blockade in the Acute Respiratory Distress Syndrome.
    ; Moss M; Huang DT; Brower RG; Ferguson ND; Ginde AA; Gong MN; Grissom CK; Gundel S; Hayden D; Hite RD; Hou PC; Hough CL; Iwashyna TJ; Khan A; Liu KD; Talmor D; Thompson BT; Ulysse CA; Yealy DM; Angus DC
    N Engl J Med; 2019 May; 380(21):1997-2008. PubMed ID: 31112383
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Paediatric Acute Respiratory Distress Syndrome Neuromuscular Blockade study (PAN-study): a phase IV randomised controlled trial of early neuromuscular blockade in moderate-to-severe paediatric acute respiratory distress syndrome.
    Rudolph MW; Slager S; Burgerhof JGM; van Woensel JBM; Alffenaar JC; Wösten-van Asperen RM; de Hoog M; IJland MM; Kneyber MCJ;
    Trials; 2022 Jan; 23(1):96. PubMed ID: 35101098
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008.
    Dellinger RP; Levy MM; Carlet JM; Bion J; Parker MM; Jaeschke R; Reinhart K; Angus DC; Brun-Buisson C; Beale R; Calandra T; Dhainaut JF; Gerlach H; Harvey M; Marini JJ; Marshall J; Ranieri M; Ramsay G; Sevransky J; Thompson BT; Townsend S; Vender JS; Zimmerman JL; Vincent JL; ; ; ; ; ; ; ; ; ; ; ; ; ; ;
    Crit Care Med; 2008 Jan; 36(1):296-327. PubMed ID: 18158437
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Open-label randomized controlled trial of ultra-low tidal ventilation without extracorporeal circulation in patients with COVID-19 pneumonia and moderate to severe ARDS: study protocol for the VT4COVID trial.
    Richard JC; Yonis H; Bitker L; Roche S; Wallet F; Dupuis C; Serrier H; Argaud L; Thiery G; Delannoy B; Pommier C; Abraham P; Muller M; Aubrun F; Sigaud F; Rigault G; Joffredo E; Mezidi M; Terzi N; Rabilloud M
    Trials; 2021 Oct; 22(1):692. PubMed ID: 34635128
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparison of fixed dose versus train-of-four titration of cisatracurium in acute respiratory distress syndrome.
    Thompson Bastin ML; Smith RR; Bissell BD; Wolf HN; Wiegand AM; Cavagnini ME; Ahmad Y; Flannery AH
    J Crit Care; 2021 Oct; 65():86-90. PubMed ID: 34118504
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The use of paralytics in patients with acute respiratory distress syndrome.
    Hraiech S; Dizier S; Papazian L
    Clin Chest Med; 2014 Dec; 35(4):753-63. PubMed ID: 25453423
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Temporal changes in the epidemiology, management, and outcome from acute respiratory distress syndrome in European intensive care units: a comparison of two large cohorts.
    Sakr Y; François B; Solé-Violan J; Kotfis K; Jaschinski U; Estella A; Leone M; Jakob SM; Wittebole X; Fontes LE; de Melo Gurgel M; Midega T; Vincent JL; Ranieri VM;
    Crit Care; 2021 Feb; 25(1):87. PubMed ID: 33632247
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [The influence of the sedation based on remifentanil analgesia on the occurrence of delirium in critically ill patients].
    Lyu J; Liu D; An Y; Feng Y
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2015 Oct; 27(10):845-9. PubMed ID: 27132450
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Considerations in Neuromuscular Blockade in the ICU: A Case Report and Review of the Literature.
    Workum JD; Janssen SHV; Touw HRW
    Case Rep Crit Care; 2020; 2020():8780979. PubMed ID: 32206357
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Decreased duration of mechanical ventilation when comparing analgesia-based sedation using remifentanil with standard hypnotic-based sedation for up to 10 days in intensive care unit patients: a randomised trial [ISRCTN47583497].
    Breen D; Karabinis A; Malbrain M; Morais R; Albrecht S; Jarnvig IL; Parkinson P; Kirkham AJ
    Crit Care; 2005 Jun; 9(3):R200-10. PubMed ID: 15987391
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Risk factors for the development of acute respiratory distress syndrome in mechanically ventilated adults in Peru: a multicenter observational study.
    Gupta E; Hossen S; Grigsby MR; Herrera P; Roldan R; Paz E; Jaymez AA; Chirinos EE; Portugal J; Quispe R; Brower RG; Checkley W;
    Crit Care; 2019 Dec; 23(1):398. PubMed ID: 31810487
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Analgesia and sedation in patients with ARDS.
    Chanques G; Constantin JM; Devlin JW; Ely EW; Fraser GL; Gélinas C; Girard TD; Guérin C; Jabaudon M; Jaber S; Mehta S; Langer T; Murray MJ; Pandharipande P; Patel B; Payen JF; Puntillo K; Rochwerg B; Shehabi Y; Strøm T; Olsen HT; Kress JP
    Intensive Care Med; 2020 Dec; 46(12):2342-2356. PubMed ID: 33170331
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Implementation of acute respiratory distress syndrome treatment strategies by critical care physicians in Liaoning Province: a multi-center investigation].
    Yu S; Ma Y; Li X
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 Jun; 32(6):754-759. PubMed ID: 32684226
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Use of Venovenous Extracorporeal Membrane Oxygenation in Critically-Ill Patients With COVID-19.
    Jozwiak M; Chiche JD; Charpentier J; Ait Hamou Z; Jaubert P; Benghanem S; Dupland P; Gavaud A; Péne F; Cariou A; Mira JP; Nguyen LS
    Front Med (Lausanne); 2020; 7():614569. PubMed ID: 33363190
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012.
    Dellinger RP; Levy MM; Rhodes A; Annane D; Gerlach H; Opal SM; Sevransky JE; Sprung CL; Douglas IS; Jaeschke R; Osborn TM; Nunnally ME; Townsend SR; Reinhart K; Kleinpell RM; Angus DC; Deutschman CS; Machado FR; Rubenfeld GD; Webb SA; Beale RJ; Vincent JL; Moreno R;
    Crit Care Med; 2013 Feb; 41(2):580-637. PubMed ID: 23353941
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Systematic evaluation of neuromuscular blocking agents on prognosis of patients with moderate to severe acute respiratory distress syndrome].
    Gao ZW; Zhao HM; Sun QS; Sun H; Huang YZ; Zheng P
    Zhonghua Yi Xue Za Zhi; 2019 Dec; 99(48):3819-3825. PubMed ID: 31874521
    [No Abstract]   [Full Text] [Related]  

  • 60. Effect of Nebulized Heparin on Weaning off Intubated Patients with Acute Respiratory Distress Syndrome (ARDS) Admitted to Intensive Care Unit (ICU): A Randomized Clinical Trial.
    Olapour A; Rashidi M; Javaher Foroush F; Akhoondzadeh R; Hosseini N
    Anesth Pain Med; 2021 Oct; 11(5):e115938. PubMed ID: 35075409
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.